Sort
261,768 grants matching “gene therapy”
Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome
$994,300Kenneth Cundy · Anebulo Pharmaceuticals, Inc. · U01 · FY2025 · DA
A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma
$994,294Stephen H Thorne · Western Oncolytics, Ltd · R44 · FY2020 · CA
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
$994,272Ryan David Wuebbles · Strykagen Corporation · R44 · FY2024 · OD
Neurocognitive Aging: Epigenetic Dynamics, Plasticity and Network Contributions
$994,236Peter R Rapp · National Institute On Aging · ZIA · FY2015 · AG
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility
$994,203Masahiro Yamashita · Columbia University Health Sciences · R61 · FY2025 · AI
A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance
$994,179Neil A Fanger · Virtici, Llc · R44 · FY2021 · AI
ExRNA Mouse Core
$994,078Michael T McManus · University Of California, San Francisco · U19 · FY2017 · CA
Novel Diagnostic Sequencing System for HIV Resistance Testing
$994,055Jerzy Olejnik · Intelligent Bio-Systems, Inc. · R44 · FY2011 · AI
A platform for high-throughput production of targeting systems for cell-type-specific transgene expression in wild-type animals
$993,992Ian R Wickersham · Massachusetts Institute Of Technology · R01 · FY2016 · MH
Optimization of an in vivo base editing strategy to treat SOD1-linked ALS
$993,968Thomas Gaj · University Of Illinois At Urbana-Champaign · U01 · FY2025 · NS
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation
$993,934Craig Gelfand · Advent Therapeutics, Inc. · R44 · FY2024 · HL
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
$993,911David J Rawlings · Seattle Children'S Hospital · R01 · FY2009 · AI
Discovery of B. pseudomallei therapeutics for Biodefense
$993,879Donald T Moir · Microbiotix, Inc · R44 · FY2006 · AI
STING Activators as Therapy for Cancer
$993,879Glen N Barber · Stinginn, Llc · R42 · FY2023 · CA
Novel strategy to block AAV neutralizing antibody activity
$993,865Charles H Askew · Nabgen, Inc. · R42 · FY2025 · TR
Improving marginal allograft outcomes through cell junction stabilization in transplantation
$993,803Christina Grek · Xequel Bio, Inc. · R44 · FY2021 · DK
Models for Vision Research
$993,798Patsy M Nishina · Jackson Laboratory · R01 · FY2010 · EY
HIV Persistence During Suppressive Antiretroviral Therapy
$993,764Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$993,747Roger L Shapiro · Harvard School Of Public Health · U01 · FY2023 · AI
Demystifying Disorders of Bicistronic Calcium Channel Genes
$993,747Christopher Manuel Gomez · University Of Chicago · R35 · FY2020 · NS
The differential diagnosis and treatment of Cushing's syndrome
$993,704Lynnette Nieman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$993,703Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$993,629Benjamin Michael Looney · Inspira Therapeutics, Inc. · R44 · FY2021 · DK
H. pylori-Induced Inflammation and gastric cancer
$993,628Richard M Peek · Vanderbilt University Medical Center · P01 · FY2016 · CA
UCLA Pharmacogenetics and Pharmacogenomics Research Grp*
$993,608University Of California Los Angeles · U01 · FY2003 · GM